Scarica l'app Stockscreener
22.23
1.20%
-0.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Precedente Chiudi:
$22.50
Aprire:
$22.31
Volume 24 ore:
4.27M
Relative Volume:
0.53
Capitalizzazione di mercato:
$15.46B
Reddito:
$125.68M
Utile/perdita netta:
$4.81B
Rapporto P/E:
3.9345
EPS:
5.65
Flusso di cassa netto:
$-781.21M
1 W Prestazione:
-0.80%
1M Prestazione:
+6.52%
6M Prestazione:
+91.64%
1 anno Prestazione:
+85.25%
Intervallo 1D:
$22.08
$22.41
Intervallo di 1 settimana:
$22.08
$22.76
Portata 52W:
$8.73
$23.47
Roivant Sciences Ltd Stock (ROIV) Company Profile
Nome
Roivant Sciences Ltd
Settore
Industria
Telefono
441-295-5950
Indirizzo
7TH FLOOR, 50 BROADWAY, LONDON
Confronta ROIV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
22.23 | 15.65B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.90 | 117.47B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.97 | 82.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.59 | 52.94B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
844.92 | 52.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.88 | 37.84B | 447.02M | -1.18B | -906.14M | -6.1812 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-02 | Iniziato | Citigroup | Buy |
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2024-01-05 | Iniziato | Piper Sandler | Overweight |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-10-17 | Iniziato | Guggenheim | Buy |
| 2023-06-08 | Iniziato | BofA Securities | Neutral |
| 2022-10-27 | Iniziato | JP Morgan | Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Iniziato | Goldman | Buy |
| 2021-11-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-28 | Iniziato | Citigroup | Buy |
| 2021-10-26 | Iniziato | Cowen | Outperform |
| 2021-10-26 | Iniziato | Jefferies | Buy |
| 2021-10-26 | Iniziato | Truist | Buy |
Mostra tutto
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Capricorn Fund Managers Ltd Buys New Stake in Roivant Sciences Ltd. $ROIV - MarketBeat
Insider Confidence In December 2025's Leading Growth Companies - Yahoo! Finance Canada
Reassessing Roivant Sciences (ROIV) Valuation After Pipeline Progress, NDA Timelines and Genevant Litigation Updates - simplywall.st
Voya Investment Management LLC Grows Stock Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Is Roivant Sciences Ltd stock positioned for digital transformationGap Down & High Conviction Trade Alerts - moha.gov.vn
What margin trends mean for Roivant Sciences Ltd. stockFibonacci Extensions & Fast Profit Trading Tips - bollywoodhelpline.com
Ramaswamy-Backed Ambros Launches with $125M - Orange County Business Journal
Roivant Sciences president Sukhatme sells $619k in shares By Investing.com - Investing.com Australia
Roivant Sciences president Sukhatme sells $619k in shares - Investing.com UK
How Investors May Respond To Roivant Sciences (ROIV) Accelerating Brepocitinib Timelines And Patent Litigation - simplywall.st
H.C. Wainwright Keeps Buy Rating on Roivant Sciences (ROIV) Stock - MSN
Why Roivant Sciences Ltd. stock is in analyst buy zone2025 Fundamental Recap & Reliable Entry Point Trade Alerts - Улправда
US Market Recap: What margin trends mean for Roivant Sciences Ltd stockJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - moha.gov.vn
Sell Signal: Will Roivant Sciences Ltd stock maintain momentum in 2025Weekly Stock Report & Pattern Based Trade Signal System - moha.gov.vn
Why Roivant Sciences Ltd. stock could be next big winner2025 Trading Recap & Stepwise Trade Signal Implementation - ulpravda.ru
Can Roivant Sciences Ltd. stock maintain operating marginsJuly 2025 Chart Watch & Accurate Buy Signal Notifications - Улправда
How Roivant Sciences Ltd. (87S) stock reacts to fiscal policiesJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - Улправда
Roivant Sciences (NASDAQ:ROIV) Insider Mayukh Sukhatme Sells 26,831 Shares - MarketBeat
Pres Sukhatme Sells 26,831 ($619.5K) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Can Roivant Sciences Ltd. stock double in next 5 yearsWeekly Market Summary & Daily Technical Stock Forecast Reports - ulpravda.ru
Can Roivant Sciences Ltd. stock outperform in 2025 bull marketMarket Activity Summary & High Conviction Buy Zone Alerts - DonanımHaber
Why Roivant Sciences Ltd. stock remains undervaluedVolume Spike & Consistent Return Strategy Ideas - Bölüm Sonu Canavarı
Will Roivant Sciences Ltd. stock maintain momentum in 2025Weekly Stock Analysis & Long-Term Growth Plans - DonanımHaber
Roivant Sciences Insider Sold Shares Worth $39,065,213, According to a Recent SEC Filing - marketscreener.com
Published on: 2025-12-19 09:31:09 - ulpravda.ru
Will Roivant Sciences Ltd. stock deliver shareholder valueQuarterly Trade Report & Long-Term Safe Return Strategies - Улправда
Roivant Sciences (NASDAQ:ROIV) Director Daniel Allen Gold Sells 777,332 Shares - MarketBeat
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Director Sells 917,282 Shares of Stock - MarketBeat
Roivant Sciences (ROIV) director discloses indirect sales of common shares - Stock Titan
Owner QVT Financial LP Sells 1,694,614 ($39.1M) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Why Roivant Sciences Ltd. stock remains resilientJuly 2025 Drop Watch & Free Real-Time Market Sentiment Alerts - ulpravda.ru
Why analysts remain bullish on Roivant Sciences Ltd. stock2025 Analyst Calls & Accurate Entry and Exit Point Alerts - Улправда
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - AOL.com
Published on: 2025-12-18 16:03:55 - Улправда
Roivant Sciences Insider Sold Shares Worth $37,723,200, According to a Recent SEC Filing - marketscreener.com
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million? - The Motley Fool
Insider Selling: Roivant Sciences (NASDAQ:ROIV) CEO Sells 1,740,000 Shares of Stock - MarketBeat
Pres Sukhatme Files To Sell 26,831 Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Valeo Financial Advisors LLC Purchases New Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (NASDAQ:ROIV) Sets New 12-Month HighShould You Buy? - MarketBeat
Roivant Sciences (ROIV): Reassessing Valuation After Bullish Pipeline and Patent Milestone Updates - simplywall.st
Leerink Partners Maintains Roivant Sciences (ROIV) Outperform Recommendation - Nasdaq
Roivant Sciences stock hits all-time high at 22.45 USD By Investing.com - Investing.com Australia
Insider Selling: Roivant Sciences (NASDAQ:ROIV) Major Shareholder Sells $16,752,432.88 in Stock - MarketBeat
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares By Investing.com - Investing.com South Africa
Roivant Sciences (ROIV): Ramaswamy Vivek sells $67.9 million in shares - Investing.com
Owner Ramaswamy Sells 3,103,745 ($67.9M) Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
CEO Gline Files To Sell 1,740,000 Of Roivant Sciences Ltd [ROIV] - TradingView — Track All Markets
Immunovant (IMVT) Is Up 14.0% After Roivant-Backed $550 Million Equity Raise For IMVT-1402Has The Bull Case Changed? - Yahoo! Finance Canada
Roivant Sciences (NASDAQ:ROIV) Given New $33.00 Price Target at The Goldman Sachs Group - MarketBeat
Roivant Sciences stock price target raised to $26 from $23 at H.C. Wainwright - Investing.com Australia
Roivant Sciences Ltd Azioni (ROIV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.08%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):